Turner Pope Research Note on indicative proposal

Turner Pope Investments releases a new research note following a conditional, non-binding, indicative proposal for the acquisition of its Orexin-1 (‘Ox-1’) and dopamine transporter ‘(DAT’) programmes. Read more
Filter by:

Regulatory News

Videos

down chevron